肥胖相关晚期糖基化终末产物对子宫内膜上皮细胞增殖的有害作用可被抗氧化剂缓解
研究探讨晚期糖基化终末产物(AGE)对子宫内膜上皮细胞的影响及干预。ECC-1细胞暴露于肥胖或瘦者子宫液浓度的AGE,抗氧化剂组合可恢复被AGE降低的增殖率。类器官中AGE增加CXCL16分泌(P=0.006),临床样本中CXCL16与母亲BMI(R=0.264,P=0.021)及宫内葡萄糖浓度(R=0.736,P<0.0001)正相关。
要点
- 肥胖者子宫液浓度的AGE降低ECC-1细胞增殖,抗氧化剂可恢复至瘦者水平。
- AGE以供体依赖方式影响类器官来源原代子宫内膜上皮细胞增殖。
- AGE增加类器官CXCL16分泌,临床子宫液中CXCL16与BMI和宫内葡萄糖正相关。
核心结论
- 生理相关浓度的AGE改变子宫内膜上皮细胞功能,抗氧化剂恢复AGE处理的ECC-1细胞增殖率,类器官中AGE改变增殖和CXCL16分泌。
研究设计与样本
- ECC-1细胞暴露于生理代表瘦或肥胖个体子宫液浓度的AGE及三种潜在治疗药物。
- 原代子宫内膜上皮细胞以类器官培养,在AGE存在下表征增殖和细胞因子分泌(n=5)。
- 接受辅助生殖女性的子宫液分析AGE相关炎症标志物(n=77)。
主要发现
- ECC-1增殖被肥胖条件AGE降低,与瘦条件相比P=0.04,与载体对照相比P<0.001。
- 抗氧化剂将AGE处理的ECC-1增殖恢复至对应瘦条件的水平。
- AGE以供体依赖方式影响类器官来源原代子宫内膜上皮细胞增殖。
- AGE增加类器官促炎细胞因子CXCL16分泌(P=0.006)。
- 子宫液中CXCL16与母亲BMI正相关(R=0.264,P=0.021),与宫内葡萄糖浓度正相关(R=0.736,P<0.0001)。
关键数值与推荐
- AGE浓度生理代表瘦或肥胖个体子宫液水平。
- RAGE拮抗剂FPS-ZM1 25 nmol/l、二甲双胍100 μmol/l或抗氧化剂组合(N-乙酰-L-半胱氨酸10 μmol/l、N-乙酰-L-肉碱10 μmol/l和α-硫辛酸5 μmol/l)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Advanced glycation end-products (AGE) are elevated in the uterine environment of obese infertile women. Can the detrimental effects of AGE on endometrial epithelial cells be mitigated with therapeutics, and recapitulated in a more physiologically relevant primary model (organoids)? DESIGN: Human endometrial epithelial cells (ECC-1) were exposed to AGE at concentrations physiologically representative of uterine fluid in lean or obese individuals, and three potential therapeutics: 25 nmol/l receptor for AGE (RAGE) antagonist FPS-ZM1, 100 μmol/l metformin, or a combination of antioxidants (10 μmol/l N-acetyl-l-cysteine, 10 μmol/l N-acetyl-l-carnitine and 5 μmol/l α-lipoic acid). Real-time cell analysis (xCELLigence, ACEA Biosciences) determined the rate of adhesion and proliferation. The proliferation of organoid-derived cells and secretion of cytokines from organoids was characterized in the presence of AGE (n = 5). The uterine fluid of women undergoing assisted reproduction was profiled for AGE-associated inflammatory markers (n = 77). RESULTS: ECC-1 proliferation was reduced by AGE from obese versus lean conditions and vehicle control (P = 0.04 and P < 0.001, respectively), and restored to a proliferation corresponding to lean conditions by antioxidants. AGE influenced organoid derived primary endometrial epithelial cell proliferation in a donor-dependent manner. AGE increased the organoid secretion of the proinflammatory cytokine CXCL16 (P = 0.006). Clinically, CXCL16 correlated positively to maternal body mass index (R = 0.264, P = 0.021) and intrauterine glucose concentration (R = 0.736, P < 0.0001). CONCLUSIONS: Physiologically relevant concentrations of AGE alter endometrial epithelial cell function. Antioxidants restore the rate of proliferation of AGE-treated endometrial epithelial (ECC-1) cells. Primary endometrial epithelial cells, cultured as organoids, demonstrate altered proliferation and CXCL16 secretion in the presence of AGE equimolar with the uterine fluid from obese individuals.
引用
- Hutchison JC, Evans J, Edgell TA, et al. Detrimental actions of obesity-associated advanced glycation end-products on endometrial epithelial cell proliferation are alleviated by antioxidants. Reprod Biomed Online. 2023. PMID: 37142478. doi:10.1016/j.rbmo.2023.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。